A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia
ABSTRACT Importance Apart from Huntington's disease, little is known of the genetics of autosomal dominant chorea associated with dystonia. Here we identify adenylate cyclase 5 (ADCY5) as a likely new causal gene for early‐onset chorea and dystonia. Observations Whole exome sequencing in a thre...
Saved in:
Published in | Movement disorders Vol. 30; no. 3; pp. 423 - 427 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.03.2015
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | ABSTRACT
Importance
Apart from Huntington's disease, little is known of the genetics of autosomal dominant chorea associated with dystonia. Here we identify adenylate cyclase 5 (ADCY5) as a likely new causal gene for early‐onset chorea and dystonia.
Observations
Whole exome sequencing in a three‐generation family affected with autosomal dominant chorea associated with dystonia identified a single de novo mutation—c.2088+1G>A in a 5' donor splice‐site of ADCY5—segregating with the disease. This mutation seeming leads to RNA instability and therefore ADCY5 haploinsufficiency.
Conclusions and Relevance
Our finding confirms the genetic/clinical heterogeneity of the disorder; corroborated by previous identification of ADCY5 mutations in one family with dyskinesia‐facial myokymia and in two unrelated sporadic cases of paxoysmal choreic/dystonia‐facial myokymia; ADCY5's high expression in the striatum and movement disorders in ADCY5‐deficient mice. Hence ADCY5 genetic analyses may be relevant in the diagnostic workup of unexplained early‐onset hyperkinetic movement disorders. © 2014 International Parkinson and Movement Disorder Society |
---|---|
Bibliography: | istex:7FE5845201E67E1A8EC8FD6BA96D81237D9519D8 ArticleID:MDS26115 ark:/67375/WNG-BV3FB6L1-5 This study was supported by funds from the Strasbourg High Throughput Next Generation Sequencing facility (GENOMAX) and INSERM UMR_S 1109. Nothing to report. These authors contributed equally to this work Relevant conflicts of interest/financial disclosures Author roles may be found in the online version of this article. Funding agencies ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0885-3185 1531-8257 |
DOI: | 10.1002/mds.26115 |